Company intelligence / Profile preview
Immuno Cure
Hong Kong, Hong Kong
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Immuno Cure is a Hong Kong-based biotechnology company dedicated to the development of innovative DNA vaccines and immunotherapies for infectious diseases and oncology. The company utilizes its proprietary PD-1-enhanced DNA vaccine platform, DNAVAX, which is designed to enhance immune responses by targeting antigens to dendritic cells via a soluble PD-1 protein. Its lead clinical candidate, ICVAX, is a therapeutic vaccine for HIV-1 infection currently undergoing Phase 2 clinical trials. Additionally, the company is developing ICCOV, a DNA vaccine candidate for COVID-19, and exploring applications in cancer immunotherapy. Immuno Cure maintains a close strategic collaboration with the University of Hong Kong's AIDS Institute to translate cutting-edge research into clinical solutions.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- DNA vaccineImmunotherapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
University of Hong KongAIDS Institute of the University of Hong Kong
Beyond the preview
Go deeper on Immuno Cure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immuno Cure.